Inquirer Technology on MSN4d
US approves 1st fast-acting insulin biosimilar for diabetesThe US Food and Drug Administration approved the first-ever rapid-acting insulin for reducing blood sugar levels. It calls ...
The Healthy on MSN5d
More Than 900,000 Diabetes Devices Have Been Recalled NationwideAccording to 2021 data from the American Diabetes Association, 2 million Americans have type 1 diabetes—304,000 of which are ...
Insulin-aspart-szjj is the first rapid-acting insulin biosimilar approved and the third insulin product approved by the FDA.
Tandem Diabetes Care, Inc.’s Control-IQ+ Technology, used with the t:slim and Mobi insulin pumps, becomes the second AID ...
FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...
Tandem is following competitor Insulet’s lead with the second automated insulin delivery system indicated for Type 2 diabetes ...
6don MSN
Why it matters: More than 3.5 million Californians have diabetes, and insulin is a life-saving part of their disease ...
Metformin is the most commonly prescribed oral drug for diabetes. Of course, if you or a loved one receives treatment for ...
2don MSN
President Donald Trump’s pick to lead the US Food and Drug Administration told senators in a tense confirmation hearing ...
Dr. Marty Makary, Trump's nominee for FDA Commissioner, breezed through his confirmation hearing despite tough questions from Democrats and Republicans.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback